GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.
about
Prefrontal Cortex and Social Cognition in Mouse and ManCortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulationCross-talk and regulation between glutamate and GABAB receptorsThe role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.Tiagabine improves hippocampal long-term depression in rat pups subjected to prenatal inflammationProspective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of AutismTranslational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.Phencyclidine Disrupts the Auditory Steady State Response in RatsMaternal Exposure of Rats to Isoflurane during Late Pregnancy Impairs Spatial Learning and Memory in the Offspring by Up-Regulating the Expression of Histone Deacetylase 2.Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.Spontaneous Gamma Activity in Schizophrenia.Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models.Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in miceBrain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model.Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function.Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit.GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.Neuroimaging biomarkers for early drug development in schizophreniaElectrophysiological intermediate biomarkers for oxidative stress in schizophreniaEnhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autismIntegrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophreniaCeftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice.Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivoAltered neural connectivity in excitatory and inhibitory cortical circuits in autism.Sensory encoding in Neuregulin 1 mutantsThe role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Complex GABAB receptor complexes: how to generate multiple functionally distinct units from a single receptor.Role of murine models in psychiatric illness drug discovery: a dimensional view.Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology.Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges.Cellular and circuit models of increased resting-state network gamma activity in schizophreniaAltering the course of schizophrenia: progress and perspectives.
P2860
Q26774748-5F9083A7-FE5C-4E3A-821F-22B1483272ACQ26853430-D64E6A3B-1063-4FE1-9524-6DE550FAACADQ26861100-458339EF-163E-48A2-847B-2406DA8509A1Q26998975-19E37426-2238-4889-BA32-D78C328DA85CQ27313386-13BA8C6E-705C-4BAB-8848-7DF6E101413DQ28083480-B9A4657C-3242-4E25-9609-E7036274BFF9Q28391720-AB45DAD0-C57B-4FC3-A232-5A88A2715C95Q28394524-922C3D89-C2C8-4E07-9028-C87A951DB350Q28547137-00B86833-40D6-4442-BD74-17CA2C5EB77EQ30276097-4AC8E841-5DC1-40C8-B627-4110F97432B3Q30354621-5CC78E4E-1018-4030-B3A5-EA9D91B5ECA6Q30362017-9CC72BBE-5901-45AF-920A-CB3FF1C9964DQ30363617-D55055C5-6171-4242-B6A7-58ADE7E9FF55Q30377860-0130121A-B330-4E7E-83D5-289A36116A9DQ30388341-5C132DC4-CAEA-40E7-A915-E8275380C6C3Q30407741-901C9180-0F8D-4173-9071-F2EE5F2FEEFEQ30416848-DF77E5CB-0567-4EA3-A141-527DAC15518AQ30421694-288D5438-07DA-4BCD-BAB2-7F7BA5FDCD3FQ30435025-EE32B309-959F-46C4-AFAE-7FD3D94805C2Q30446951-03267F01-7700-448F-9C8D-254D36D4FF04Q30578270-2363DD1E-2B57-461F-946B-00D3674B590FQ30629661-322129A8-2D98-49ED-8083-EA0E2D0634BBQ33573692-C3A22913-642D-438D-AADB-4543204437DEQ33632516-BB3704DA-5FF9-4B90-816F-3E7AF73104EEQ33647885-ABF88709-32A6-499F-95FA-BD542FF1B80CQ33837604-2994375D-F044-489E-88CC-EAC56981CB7EQ33945211-058D0790-85C8-47BE-B5A5-8DA84BD39627Q35872055-BF743EBF-CA67-43B8-945D-9142CE9FD3BBQ36248928-F89A4426-D81C-49DE-9D78-2A1A458F9148Q36990973-E6023DBE-D209-4361-89AC-87027B1F4369Q37177032-6487A313-3CD7-41C7-BB4B-C94B2B836954Q37201156-9ABA1850-3251-4709-869E-2FD185F7CC1CQ37292555-5E8BDEFA-B4D3-442F-A20D-FC410C52FEDAQ37559828-7ABF81C7-9A6A-4E30-9A4F-4A4CAC8705D1Q37576739-E23B7875-25AC-4DAA-912F-1734B9E74865Q38104781-B500A26C-E2D5-44B6-B164-41F008E71F93Q38299791-A9A37FFC-CCA4-4A7A-BC41-B15FCAF46005Q38310750-5FFA53D3-56E5-4CB3-8D6B-A83C9234B309Q38636247-B6A17236-78B2-4D77-9D0E-99A6C0EE4656Q38759421-580AC91D-B2CB-4041-B676-7E99A2386AAE
P2860
GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
GABAB-mediated rescue of alter ...... onstitutive NMDAR-hypofunction
@nl
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@ast
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@en
type
label
GABAB-mediated rescue of alter ...... onstitutive NMDAR-hypofunction
@nl
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@ast
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@en
prefLabel
GABAB-mediated rescue of alter ...... onstitutive NMDAR-hypofunction
@nl
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@ast
GABAB-mediated rescue of alter ...... nstitutive NMDAR-hypofunction.
@en
P2093
P2860
P3181
P356
P1476
GABAB-mediated rescue of alter ...... onstitutive NMDAR-hypofunction
@en
P2093
P I Ortinski
R Anderson
R C Pierce
P2860
P2888
P3181
P356
10.1038/TP.2012.69
P407
P577
2012-07-17T00:00:00Z
P5875
P6179
1013217375